EP1883418A4
Sclerostin and the inhibition of wnt signaling and bone formation
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO03106657A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-5,12-18,25-31,38-48,55-63,70-78,85-89,113 |
| US2004038860A1 | Cites | United States of America | I | Search report | 1-89,113 |
| WO2005014650A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-5,12-18,25-31,38-48,55-63,70-78,85-89,113 |
| LI XIAOFENG ET AL: "Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC, US, vol. 280, no. 20, 18 March 2005 (2005-03-18), pages 19883 - 19887, XP002391780, ISSN: 0021-9258, DOI: 10.1074/JBC.M413274200 | Non-patent | – | – | Search report | – |
121 members in 7 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 84668 | United States of America | – | |
| 8466805 | United States of America | A | |
| 2006009697 | United States of America | W |
Members121
| Document | Office | Kind | |
|---|---|---|---|
| US2005074223A1 | United States of America | A1 | |
| US2005196349A1 | United States of America | A1 | |
| CA2567023A1 | Canada | A1 | |
| CA2771940A1 | Canada | A1 | |
| CA2771941A1 | Canada | A1 | |
| CA2771951A1 | Canada | A1 | |
| CA2772029A1 | Canada | A1 | |
| CA2772033A1 | Canada | A1 | |
| WO2005115354A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2006030523A1 | United States of America | A1 | |
| US2006198791A2 | United States of America | A2 | |
| CA2601360A1 | Canada | A1 | |
| CA2814267A1 | Canada | A1 | |
| CA2929206A1 | Canada | A1 | |
| WO2006102070A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2603642A1 | Canada | A1 | |
| CA2886311A1 | Canada | A1 | |
| CA2886314A1 | Canada | A1 | |
| CA2886316A1 | Canada | A1 | |
| CA2923650A1 | Canada | A1 | |
| CA2964644A1 | Canada | A1 | |
| WO2006107719A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1758562A2 | European Patent Office (EPO) | A2 | |
| IL179241A0 | Israel | A0 | |
| US7203412B2 | United States of America | B2 | |
| WO2005115354A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1868633A2 | European Patent Office (EPO) | A2 | |
| IL186010A0 | Israel | A0 | |
| IL186400A0 | Israel | A0 | |
| EP1883418A2 | European Patent Office (EPO) | A2 | |
| JP2008505190A | Japan | A | |
| US2008119402A1 | United States of America | A1 | |
| JP2008536816A | Japan | A | |
| JP2008537744A | Japan | A | |
| CN101316627A | China | A | |
| CA2669825A1 | Canada | A1 | |
| WO2009035430A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2006102070A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2006107719A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1758562A4 | European Patent Office (EPO) | A4 | |
| WO2009035430A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN101578399A | China | A | |
| WO2009035430A8 | World Intellectual Property Organization (WIPO) | A8 | |
| EP2134171A2 | European Patent Office (EPO) | A2 | |
| CA2732013A1 | Canada | A1 | |
| CA3012497A1 | Canada | A1 | |
| CA3126121A1 | Canada | A1 | |
| WO2010017472A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL198684A0 | Israel | A0 | |
| CA2733670A1 | Canada | A1 | |
| US2010041599A1 | United States of America | A1 | |
| WO2010019878A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CN101657096A | China | A | |
| US2010074891A1 | United States of America | A1 | |
| CN101888849A | China | A | |
| US2010298200A1 | United States of America | A1 | |
| US2010298308A1 | United States of America | A1 | |
| JP2010537950A | Japan | A | |
| IL209849A0 | Israel | A0 | |
| IL209850A0 | Israel | A0 | |
| US2011086021A1 | United States of America | A1 | |
| US2011105606A1 | United States of America | A1 | |
| EP2324356A1 | European Patent Office (EPO) | A1 | |
| EP2326954A1 | European Patent Office (EPO) | A1 | |
| IL209848A0 | Israel | A0 | |
| EP2324356A4 | European Patent Office (EPO) | A4 | |
| EP2409732A1 | European Patent Office (EPO) | A1 | |
| EP2326954A4 | European Patent Office (EPO) | A4 | |
| EP1868633A4 | European Patent Office (EPO) | A4 | |
| US2012115787A9 | United States of America | A9 | |
| CA2567023C | Canada | C | |
| US2012178697A9 | United States of America | A9 | |
| US2012178747A9 | United States of America | A9 | |
| US2012184616A9 | United States of America | A9 | |
| JP4993623B2 | Japan | B2 | |
| EP2134171A4 | European Patent Office (EPO) | A4 | |
| EP1883418A4This record | European Patent Office (EPO) | A4 | |
| EP1758562B1 | European Patent Office (EPO) | B1 | |
| US2012322717A9 | United States of America | A9 | |
| US8367822B2 | United States of America | B2 | |
| US8461155B2 | United States of America | B2 | |
| CA2601360C | Canada | C | |
| US2013172332A1 | United States of America | A1 | |
| EP2615456A1 | European Patent Office (EPO) | A1 | |
| US2013251735A1 | United States of America | A1 | |
| EP1868633B1 | European Patent Office (EPO) | B1 | |
| US8637506B2 | United States of America | B2 | |
| CN101657096B | China | B | |
| IL198684A | Israel | A | |
| CA2771951C | Canada | C | |
| EP2134171B1 | European Patent Office (EPO) | B1 | |
| US8969339B2 | United States of America | B2 | |
| CA2771941C | Canada | C | |
| EP2324356B1 | European Patent Office (EPO) | B1 | |
| US9046537B2 | United States of America | B2 | |
| US9052324B2 | United States of America | B2 | |
| EP2134171B9 | European Patent Office (EPO) | B9 | |
| CA2603642C | Canada | C | |
| US2015216832A1 | United States of America | A1 | |
| EP2910550A2 | European Patent Office (EPO) | A2 |
Showing 100 of 121
20 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Deferred search report published (corrected)R17D | R17D | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1883418
- Application
- 67387258
Titles3
- German
- SCLEROSTIN UND HEMMUNG DER WNT-SIGNALÜBERTRAGUNG UND KNOCHENBILDUNG
- English
- SCLEROSTIN AND THE INHIBITION OF WNT SIGNALING AND BONE FORMATION
- French
- SCLEROSTINE ET INHIBITION DE LA SIGNALISATION PAR LE WNT, ET FORMATION OSSEUSE
Classification
- CPC, 9
- G01N33/6893
- G01N33/6887
- G01N2500/00
- G16B5/00
- A61P19/00
- A61P19/08
- A61P19/10
- A61P35/00
- A61P43/00
- IPC, 11
- A61K31 538
- A61K9 68
- A61K31 015
- A61K38 17
- C07C45 27
- C07D265 38
- G01N33 48
- G01N33 50
- G01N33 53
- G01N33 68
- G06F19 00
Designated states31
- Contracting states, 31
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Netherlands (Kingdom of the)
and 7 moreShow fewer
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
